S1 Opioid Receptor Agonists and Serum Prostate-Specific Antigen Level: Is There a Role for Prostate Cancer Control and Chemoprevention?

    September 2010 in “ European Urology Supplements
    Saba Hosseini, Mohammad Reza Safarinejad, Erfan Amini
    Image of study
    TLDR Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.
    The document presents findings from several studies related to prostate cancer, with a focus on the role of opioid receptor agonists, the reliability of prostate-specific antigen (PSA) testing, the association between serum triglyceride levels and prostate cancer risk, and the measurement of urethral PSA levels after radical prostatectomy. In the first study, a case-control study of 29 opium users and 39 non-users in an Iranian population found a significant association between opium consumption and lower serum PSA levels, suggesting a potential role for opioids in prostate cancer control. The mean serum PSA level was 0.91±0.87 ng/dL in opium users compared to 1.7±0.91 ng/dL in controls (p<0.001). The second study evaluated the positive predictive value of PSA testing in 358 men undergoing prostate biopsies. It found that the positive predictive value of total serum PSA was 51.4%, and there was a significant association between PSA levels, PSA density, and the presence of prostate cancer. The study recommended the use of PSA testing for detecting malignant prostate lesions, suggesting that increasing the number of biopsy cores and using transrectal ultrasound (TRUS) could improve diagnostic accuracy. The third study, a prospective multicenter case-control study with 194 prostate cancer cases and 317 controls, found no significant association between serum triglyceride levels and prostate cancer risk, challenging the hypothesis that triglycerides are involved in prostate cancer pathogenesis. Lastly, a study of 45 patients after radical prostatectomy reported that higher urethral PSA (urPSA) levels were associated with higher androgenic alopecia scores and higher postoperative PSA levels, indicating a possible link between local dihydrotestosterone activity and PSA secretion. Overall, these studies contribute to the understanding of factors associated with prostate cancer risk and the utility of PSA testing in diagnosis and postoperative monitoring.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 12 results

      community So we’re just ok with taking a research chemical now?

      in Treatment  181 upvotes 3 years ago
      The conversation discusses the use of RU58841, a non-FDA approved research chemical for hair loss, with mixed opinions on its safety and effectiveness. Some users are willing to try it as a last resort after other treatments like Minoxidil and Finasteride failed, while others express concerns about potential long-term side effects and lack of official research.

      community How much do you guys think diet and sleep affects results?

      in Research/Science  37 upvotes 1 year ago
      The conversation discusses whether lifestyle factors like diet and sleep affect hair growth in people with reversible hair loss. Some believe these factors, along with treatments like minoxidil, finasteride, and RU58841, can improve hair health, while others argue hair loss is mostly determined by genetics and DHT sensitivity.

      community How uninformed the general public is about hair loss

      in Chat  313 upvotes 9 months ago
      The conversation highlights the general public's lack of knowledge about hair loss, with various ineffective remedies suggested, such as not wearing hats or using hair fibers. The only effective treatments mentioned for male pattern baldness are medications like minoxidil and finasteride, and hair transplants.

    Similar Research

    5 / 365 results